{"database": "lobbying", "table": "lobbying_activities", "rows": [[3059630, "c3db6f98-f983-4f30-af90-11b970e7f52c", "Q3", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "LUPUS FOUNDATION OF AMERICA", 2023, "third_quarter", "DIS", "Advance adequate supply of lupus medications during novel coronavirus pandemic.", "Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS)", 20000, null, 0, 0, "2023-10-19T09:20:01-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3059630"], "units": {}, "query_ms": 3.9191260002553463, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}